Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GE Junction Cancer”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Study completedNCT00165464
What this trial is testing

Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric CancerGE Junction Cancer
Dana-Farber Cancer Institute 54
Testing effectiveness (Phase 2)Study completedNCT03165994
What this trial is testing

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Esophageal CancerGastroEsophageal Cancer
Apexigen America, Inc. 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03448835
What this trial is testing

Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)

Who this might be right for
Stomach CancerGastro Esophageal Junction Cancer
The Netherlands Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT02918162
What this trial is testing

Perioperative Chemo and Pembrolizumab in Gastric Cancer

Who this might be right for
Gastric CancerAdenocarcinoma of the Gastroesophageal Junction
Gulam Manji 49
Testing effectiveness (Phase 2)Study completedNCT00086996
What this trial is testing

S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 98
Testing effectiveness (Phase 2)WithdrawnNCT00620607
What this trial is testing

HuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Who this might be right for
Stomach NeoplasmsMetastatic or Locally Advanced Gastric CancerMetastatic or Local Advanced GE Junction Cancer
ImmunoGen, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01774851
What this trial is testing

MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach

Who this might be right for
HER-2 Gene AmplificationEsophagus CancerGastroesophageal Junction Cancer+1 more
Merrimack Pharmaceuticals 84
Testing effectiveness (Phase 2)Looking for participantsNCT07632079
What this trial is testing

Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer

Who this might be right for
Locally Advanced Esophageal or GE Junction Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Very early researchStudy completedNCT00215514
What this trial is testing

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Stomach CancerGastric CancerGastro-esophageal Junction Cancer
Dana-Farber Cancer Institute 25
Testing effectiveness (Phase 2)Study completedNCT01129310
What this trial is testing

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.

Who this might be right for
Gastrointestinal NeoplasmGastric Adenocarcinoma
AHS Cancer Control Alberta 47
Testing effectiveness (Phase 2)Ended earlyNCT00103103
What this trial is testing

Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer

Who this might be right for
Gastric Cancer
California Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT00952497
What this trial is testing

Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
ACT Biotech, Inc 48
Testing effectiveness (Phase 2)Study completedNCT02317991
What this trial is testing

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Cancer
SCRI Development Innovations, LLC 65
Testing effectiveness (Phase 2)Study completedNCT00517829
What this trial is testing

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
US Oncology Research 150
Very early researchNot Yet RecruitingNCT06646783
What this trial is testing

Phase IIT Trial of SNA014

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of GE JunctionPancreatic Cancer Stage
SmartNuclide Biopharma 28
Testing effectiveness (Phase 2)Study completedNCT00381706
What this trial is testing

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 245
Testing effectiveness (Phase 2)Study completedNCT00259987
What this trial is testing

Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus

Who this might be right for
Adenocarcinoma
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Looking for participantsNCT07353684
What this trial is testing

Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer

Who this might be right for
AdebrelimabAdenocarcinoma of GE JunctionAdenocarcinoma of Stomach
Beijing Friendship Hospital 49
Not applicableLooking for participantsNCT01048281
What this trial is testing

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Who this might be right for
Stomach CancerGastro-Esophageal(GE) Junction CancerGastric (Stomach) Cancer+2 more
Stanford University 100
Early research (Phase 1)Study completedNCT03279237
What this trial is testing

A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Who this might be right for
GastroEsophageal Cancer
Massachusetts General Hospital 25
Next Page